Charming Medical faces Nasdaq trading suspension Nov. 9 unless it appeals

MCTA•2026-11-05

Nasdaq will suspend trading in Charming Medical’s listed securities at the November 9, 2026, open unless the company requests an appeal by November 5. The SEC suspended trading in the securities in November 2025 over potential third-party manipulation; Nasdaq has not communicated any finding of company wrongdoing.

1. Suspension deadline

Charming Medical received Nasdaq’s October 29, 2026, delisting determination. Trading in its Nasdaq-listed securities will be suspended at the November 9 open unless the company requests an appeal by November 5.

2. Earlier trading halt

The SEC suspended trading on November 11, 2025, over potential third-party manipulation, after which Nasdaq halted trading. Nasdaq has not communicated any finding of company wrongdoing.

Sources

Charming Medical faces Nasdaq trading suspension Nov. 9 unless it appeals

Sec

Charming Medical faces Nasdaq trading suspension Nov. 9 unless it appeals

1. Suspension deadline

2. Earlier trading halt

Related News

First Industrial Realty Trust, Inc.: Truist Securities cuts target price to $62 from $73

Lincoln International Q3 net income drops 80% to $9.94 million

McGraw Hill Q2 FY27 net income drops 18% to $86.38 million; revenue falls 6% to $632.21 million

Sources

Charming Medical faces Nasdaq trading suspension Nov. 9 unless it appeals

Grand Canyon Education target price cut to $180 from $200

Korro Bio presents KRRO-121 development plan, targets interim data in second half of 2027